Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
Titel:
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
Auteur:
Stacchiotti, S. Saponara, M. Frapolli, R. Tortoreto, M. Cominetti, D. Provenzano, S. Negri, T. Dagrada, G.P. Gronchi, A. Colombo, C. Vincenzi, B. Badalamenti, G. Zuco, V. Renne, S.L. Collini, P. Morosi, C. Dei Tos, A.P. Bello, E. Pilotti, S. Casali, P.G. D'Incalci, M. Zaffaroni, N.